TFS
NVO

Thoroughbred Financial Services’s Novo Nordisk NVO Stock Holding History

Thoroughbred Financial Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,327
Closed -$367K – 580
2025
Q2 		$367K Sell
5,327
-14,061
-73% -$956K 0.03% 424
2025
Q1 		$1.35M Sell
19,388
-23,857
-55% -$1.97M 0.08% 227
2024
Q4 		$3.72M Buy
43,245
+1,444
+3% +$156K 0.23% 85
2024
Q3 		$4.98M Sell
41,801
-1,624
-4% -$217K 0.32% 63
2024
Q2 		$6.2M Buy
43,425
+21,903
+102% +$2.9M 0.41% 48
2024
Q1 		$2.76M Sell
21,522
-13,182
-38% -$1.57M 0.27% 84
2023
Q4 		$3.59M Buy
34,704
+15,167
+78% +$1.5M 0.29% 76
2023
Q3 		$1.78M Buy
19,537
+16,969
+661% +$1.49M 0.17% 128
2023
Q2 		$207K Buy
+2,568
New +$210K 0.03% 398

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Thoroughbred Financial Services's NVO Position: Q3 2025 in Review

Thoroughbred Financial Services sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 5,327 shares — an estimated $367K sold.

Thoroughbred Financial Services first reported a position in NVO in Q2 2023 and held it in 9 quarters. The position peaked at $6.2M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Thoroughbred Financial Services reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Thoroughbred Financial Services sold 5,327 Novo Nordisk shares in Q3 2025, an estimated $367K.
  • Thoroughbred Financial Services first reported a position in Novo Nordisk in Q2 2023 and held it in 9 quarters.
  • Thoroughbred Financial Services's Novo Nordisk position peaked at $6.2M in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Thoroughbred Financial Services's 13F filing for Q3 2025, filed 10 Nov 2025.